
TSX:VIVO • CA92845J1049
The current stock price of VIVO.CA is 0.025 CAD. In the past month the price increased by 25%. In the past year, price decreased by -64.29%.
ChartMill assigns a technical rating of 1 / 10 to VIVO.CA. When comparing the yearly performance of all stocks, VIVO.CA is a bad performer in the overall market: 84.66% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to VIVO.CA. VIVO.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months VIVO.CA reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS decreased by -111.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.06 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.37 | 2.952B | ||
| GSD | DEVONIAN HEALTH GROUP INC | N/A | 1.991B | ||
| CRON | CRONOS GROUP INC | 36.3 | 1.348B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.179B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 6.9 | 872.942M | ||
| GUD | KNIGHT THERAPEUTICS INC | 124.44 | 592.761M | ||
| WEED | CANOPY GROWTH CORP | N/A | 526.898M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 411.936M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 26.54 | 360.254M | ||
| TSND | TERRASCEND CORP | N/A | 287.235M |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
VIVO Cannabis, Inc. engages in the production and sale of cannabis-based products. The company is headquartered in Toronto, Ontario and currently employs 184 full-time employees. The company went IPO on 2007-08-29. The Company’s principal business activity is the production and sale of medical and adult-use cannabis and cannabis products and providing cannabis-related medical information and services in Canada. The firm has a range of of premium brands, each targeting different customer segments, including Canna Farms, Beacon Medical, Fireside, and Lumina. Harvest Medicine, the Company’s patient-centric network of medical cannabis clinics. The firm holds production and sales licenses from Health Canada and operates indoor and seasonal airhouse cultivation facilities. The company offers pharmaceutical-grade products grown in small batches in Napanee, Ontario. Its Beacon Cannabis provides navigating medical cannabis using the Beacon Cannatypes classification system. The Company’s wholly owned subsidiaries include ABcann Medicinals Inc (ABcann) and Canna Farms Limited (Canna Farms).
VIVO Cannabis Inc
180 John Street, Suite 403
TORONTO ONTARIO K7R 3L2 CA
CEO: Barry Fishman
Employees: 184
Phone: 16135074211.0
VIVO Cannabis, Inc. engages in the production and sale of cannabis-based products. The company is headquartered in Toronto, Ontario and currently employs 184 full-time employees. The company went IPO on 2007-08-29. The Company’s principal business activity is the production and sale of medical and adult-use cannabis and cannabis products and providing cannabis-related medical information and services in Canada. The firm has a range of of premium brands, each targeting different customer segments, including Canna Farms, Beacon Medical, Fireside, and Lumina. Harvest Medicine, the Company’s patient-centric network of medical cannabis clinics. The firm holds production and sales licenses from Health Canada and operates indoor and seasonal airhouse cultivation facilities. The company offers pharmaceutical-grade products grown in small batches in Napanee, Ontario. Its Beacon Cannabis provides navigating medical cannabis using the Beacon Cannatypes classification system. The Company’s wholly owned subsidiaries include ABcann Medicinals Inc (ABcann) and Canna Farms Limited (Canna Farms).
The current stock price of VIVO.CA is 0.025 CAD.
VIVO.CA does not pay a dividend.
VIVO.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
VIVO Cannabis Inc (VIVO.CA) has a market capitalization of 9.27M CAD. This makes VIVO.CA a Nano Cap stock.
VIVO Cannabis Inc (VIVO.CA) will report earnings on 2022-01-06.